Qube Research & Technologies LTD Fate Therapeutics Inc Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 35,134 shares of FATE stock, worth $135,968. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,134

Previous 11,310 210.65%

Holding current value

$135,968

Previous $83,000 38.55%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.26 - $7.08 $77,666 - $168,673	23,824 Added 210.65%	35,134 $115,000
Q1 2024 May 14, 2024	SELL	$3.54 - $8.35 $145,607 - $343,452	-41,132 Reduced 78.43%	11,310 $83,000
Q4 2023 Feb 13, 2024	SELL	$1.65 - $3.94 $554,093 - $1.32 Million	-335,814 Reduced 86.49%	52,442 $196,000
Q3 2023 Nov 13, 2023	BUY	$2.02 - $5.04 $423,410 - $1.06 Million	209,609 Added 117.33%	388,256 $823,000
Q2 2023 Aug 14, 2023	BUY	$4.76 - $6.59 $770,515 - $1.07 Million	161,873 Added 965.02%	178,647 $850,000
Q1 2023 May 15, 2023	SELL	$4.24 - $11.12 $2.01 Million - $5.28 Million	-475,208 Reduced 96.59%	16,774 $95,000
Q4 2022 Feb 14, 2023	BUY	$9.86 - $23.83 $4.62 Million - $11.2 Million	468,892 Added 2030.71%	491,982 $4.96 Million
Q3 2022 Nov 14, 2022	BUY	$21.04 - $36.06 $485,813 - $832,625	23,090 New	23,090 $517,000
Q4 2021 Feb 01, 2022	SELL	$47.84 - $64.34 $619,910 - $833,717	-12,958 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $567,688 - $916,901	-9,578 Reduced 42.5%	12,958 $768,000
Q2 2021 Aug 13, 2021	BUY	$67.25 - $92.52 $886,489 - $1.22 Million	13,182 Added 140.92%	22,536 $1.96 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $674,984 - $1.1 Million	9,354 New	9,354 $771,000
Q1 2020 May 15, 2020	SELL	$17.28 - $31.88 $235,837 - $435,098	-13,648 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$13.39 - $20.73 $182,746 - $282,923	13,648 New	13,648 $267,000

Others Institutions Holding FATE

# of Institutions

190

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $375M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Fate Therapeutics Inc Transaction History